1. Home
  2. ELVN vs SPH Comparison

ELVN vs SPH Comparison

Compare ELVN & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • SPH
  • Stock Information
  • Founded
  • ELVN 2016
  • SPH 1945
  • Country
  • ELVN United States
  • SPH United States
  • Employees
  • ELVN N/A
  • SPH N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • SPH Other Specialty Stores
  • Sector
  • ELVN Health Care
  • SPH Consumer Discretionary
  • Exchange
  • ELVN Nasdaq
  • SPH Nasdaq
  • Market Cap
  • ELVN 1.1B
  • SPH 1.2B
  • IPO Year
  • ELVN 2020
  • SPH 1996
  • Fundamental
  • Price
  • ELVN $20.29
  • SPH $18.86
  • Analyst Decision
  • ELVN Strong Buy
  • SPH
  • Analyst Count
  • ELVN 5
  • SPH 0
  • Target Price
  • ELVN $41.20
  • SPH N/A
  • AVG Volume (30 Days)
  • ELVN 573.6K
  • SPH 132.8K
  • Earning Date
  • ELVN 11-07-2025
  • SPH 11-13-2025
  • Dividend Yield
  • ELVN N/A
  • SPH 6.94%
  • EPS Growth
  • ELVN N/A
  • SPH N/A
  • EPS
  • ELVN N/A
  • SPH 1.49
  • Revenue
  • ELVN N/A
  • SPH $1,429,783,000.00
  • Revenue This Year
  • ELVN N/A
  • SPH $10.99
  • Revenue Next Year
  • ELVN $20.05
  • SPH N/A
  • P/E Ratio
  • ELVN N/A
  • SPH $12.58
  • Revenue Growth
  • ELVN N/A
  • SPH 6.29
  • 52 Week Low
  • ELVN $13.30
  • SPH $16.92
  • 52 Week High
  • ELVN $29.38
  • SPH $22.24
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 49.67
  • SPH 57.96
  • Support Level
  • ELVN $16.80
  • SPH $18.02
  • Resistance Level
  • ELVN $24.64
  • SPH $19.02
  • Average True Range (ATR)
  • ELVN 1.45
  • SPH 0.37
  • MACD
  • ELVN -0.23
  • SPH 0.03
  • Stochastic Oscillator
  • ELVN 43.11
  • SPH 87.26

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About SPH Suburban Propane Partners L.P.

Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.

Share on Social Networks: